ExpreS2ion Biotech Holding Announces Extraordinary General Meeting

• ExpreS2ion Biotech Holding will hold an extraordinary general meeting at Mindpark in Helsingborg on December 1, 2026.
• Shareholders will vote on reducing share capital by SEK 62.64 million to SEK 513,093.113, transferring the reduction to unrestricted equity.
• The proposal involves no share cancellation, leaving 39,468,701 shares with a nominal value of SEK 0.013 each.
• Related amendments would change the articles of association’s share capital limits and permitted number of shares.
• Implementation of the capital reduction is expected in March 2027, subject to authorization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ExpreS2ion Biotech Holding AB published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.